Synaptogenix Statistics
Total Valuation
Synaptogenix has a market cap or net worth of $3.30 million. The enterprise value is -$14.57 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, before market open.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Synaptogenix has 1.36 million shares outstanding. The number of shares has increased by 164.69% in one year.
Current Share Class | 1.36M |
Shares Outstanding | 1.36M |
Shares Change (YoY) | +164.69% |
Shares Change (QoQ) | +2.83% |
Owned by Insiders (%) | 0.67% |
Owned by Institutions (%) | 4.25% |
Float | 1.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.56 |
P/TBV Ratio | 0.53 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.47
Current Ratio | 17.47 |
Quick Ratio | 17.41 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.91% and return on invested capital (ROIC) is -26.31%.
Return on Equity (ROE) | -78.91% |
Return on Assets (ROA) | -17.43% |
Return on Invested Capital (ROIC) | -26.31% |
Return on Capital Employed (ROCE) | -40.74% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.71M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.37% in the last 52 weeks. The beta is 1.32, so Synaptogenix's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | -51.37% |
50-Day Moving Average | 2.91 |
200-Day Moving Average | 3.30 |
Relative Strength Index (RSI) | 30.54 |
Average Volume (20 Days) | 7,773 |
Short Selling Information
The latest short interest is 19,283, so 1.42% of the outstanding shares have been sold short.
Short Interest | 19,283 |
Short Previous Month | 21,769 |
Short % of Shares Out | 1.42% |
Short % of Float | 1.43% |
Short Ratio (days to cover) | 0.17 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.81M |
Pretax Income | -4.53M |
Net Income | -13.56M |
EBITDA | -6.81M |
EBIT | -6.81M |
Earnings Per Share (EPS) | -$10.99 |
Full Income Statement Balance Sheet
The company has $17.66 million in cash and n/a in debt, giving a net cash position of $17.66 million or $13.02 per share.
Cash & Cash Equivalents | 17.66M |
Total Debt | n/a |
Net Cash | 17.66M |
Net Cash Per Share | $13.02 |
Equity (Book Value) | 6.78M |
Book Value Per Share | 4.32 |
Working Capital | 16.71M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -4.88M |
Capital Expenditures | n/a |
Free Cash Flow | -4.88M |
FCF Per Share | -$3.60 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Synaptogenix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -164.69% |
Shareholder Yield | n/a |
Earnings Yield | -438.67% |
FCF Yield | -158.02% |
Analyst Forecast
The average price target for Synaptogenix is $14.00, which is 475.59% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.00 |
Price Target Difference | 475.59% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Apr 5, 2024 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |